Unlock stock picks and a broker-level newsfeed that powers Wall Street.
IOB - Delayed Quote DKK

ChemoMetec A/S (0DZ0.IL)

Compare
426.50
-45.20
(-9.58%)
At close: April 4 at 3:59:39 PM GMT+1
Loading Chart for 0DZ0.IL
  • Previous Close 471.70
  • Open 464.60
  • Bid 399.00 x --
  • Ask 447.80 x --
  • Day's Range 425.00 - 466.80
  • 52 Week Range 282.00 - 613.50
  • Volume 221
  • Avg. Volume 3,159
  • Market Cap (intraday) 8.807B
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) 41.57
  • EPS (TTM) 10.26
  • Earnings Date May 7, 2025
  • Forward Dividend & Yield 6.00 (2.12%)
  • Ex-Dividend Date Oct 13, 2023
  • 1y Target Est --

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in are areas of cell-based therapy, cancer, and stem cell research, development, and manufacturing of pharmaceuticals as well as production and quality control of animal semen and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; NucleoCounter SCC-100, a somatic cell counter used to measure the number of somatic cells in a milk sample; and NucleoCounter YC-100, an automated yeast cell counter used to measure the total cell count and viability of yeast cells in suspension. In addition, the company provides consumables comprising cassettes, reagents, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

chemometec.com

167

Full Time Employees

June 30

Fiscal Year Ends

Recent News: 0DZ0.IL

View More

Performance Overview: 0DZ0.IL

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

0DZ0.IL
12.97%
OMX Copenhagen 25 Index (^OMXC25)
4.06%

1-Year Return

0DZ0.IL
11.33%
OMX Copenhagen 25 Index (^OMXC25)
11.75%

3-Year Return

0DZ0.IL
48.59%
OMX Copenhagen 25 Index (^OMXC25)
4.72%

5-Year Return

0DZ0.IL
86.11%
OMX Copenhagen 25 Index (^OMXC25)
50.96%

Compare To: 0DZ0.IL

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0DZ0.IL

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    7.40B

  • Enterprise Value

    7.14B

  • Trailing P/E

    43.88

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    16.14

  • Price/Book (mrq)

    12.41

  • Enterprise Value/Revenue

    15.54

  • Enterprise Value/EBITDA

    30.11

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    40.20%

  • Return on Assets (ttm)

    24.86%

  • Return on Equity (ttm)

    40.14%

  • Revenue (ttm)

    444.4M

  • Net Income Avi to Common (ttm)

    178.67M

  • Diluted EPS (ttm)

    10.26

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    316.57M

  • Total Debt/Equity (mrq)

    1.34%

  • Levered Free Cash Flow (ttm)

    71.04M

Research Analysis: 0DZ0.IL

View More

Company Insights: 0DZ0.IL

Research Reports: 0DZ0.IL

View More

People Also Watch